Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.110
+0.010 (0.91%)
At close: Dec 5, 2025, 4:00 PM EST
1.100
-0.010 (-0.90%)
After-hours: Dec 5, 2025, 6:46 PM EST
Evogene Revenue
Evogene had revenue of $312.00K in the quarter ending September 30, 2025, a decrease of -82.63%. This brings the company's revenue in the last twelve months to $5.25M, down -26.75% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.
Revenue (ttm)
$5.25M
Revenue Growth
-26.75%
P/S Ratio
1.15
Revenue / Employee
$68,513
Employees
117
Market Cap
9.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.51M | 2.87M | 50.90% |
| Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
| Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
| Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
| Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
| Dec 31, 2019 | 753.00K | -994.00K | -56.90% |
| Dec 31, 2018 | 1.75M | -1.63M | -48.33% |
| Dec 31, 2017 | 3.38M | -3.16M | -48.30% |
| Dec 31, 2016 | 6.54M | -4.59M | -41.23% |
| Dec 31, 2015 | 11.13M | -3.38M | -23.31% |
| Dec 31, 2014 | 14.51M | -3.07M | -17.46% |
| Dec 31, 2013 | 17.58M | 509.00K | 2.98% |
| Dec 31, 2012 | 17.07M | 2.17M | 14.57% |
| Dec 31, 2011 | 14.90M | 2.34M | 18.61% |
| Dec 31, 2010 | 12.56M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
EVGN News
- 15 days ago - EverGen Infrastructure Corp. (EVGN:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Evogene Ltd. (EVGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Evogene Reports Third Quarter 2025 Financial Results - PRNewsWire
- 25 days ago - Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming - PRNewsWire
- 4 weeks ago - Evogene Schedules Third Quarter 2025 Financial Results Release - PRNewsWire
- 3 months ago - Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York - PRNewsWire
- 3 months ago - Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Evogene Reports Second Quarter 2025 Financial Results - PRNewsWire